Guy N
Well-Known Member
Medicare will now cover Provenge the expensive treatment for advanced prostate cancer. I am sure that this is welcome news for those with this disease, but I can't understand why a drug can be so terribly expensive.
One course of treatment of Provenge is $93,000 (yes that's 93 thousand dollars) and sales are expected to reach $2 billion annually by 2015.
Read More
One course of treatment of Provenge is $93,000 (yes that's 93 thousand dollars) and sales are expected to reach $2 billion annually by 2015.
Read More